ASGCT Annual Meeting
May 7-11, 2024
Baltimore, MD
Where to Find Us
Session: Nonviral Methods for Delivering Nucleic Acids
High-throughput screening platform identifies nanoparticles capable of delivering 19.5 kbp plasmid to neuronal cells in vitro and in vivo
Cherry Gupta, Ph.D.
Friday, May 10 - 4:30 PM - 4:45 PM
Location: Room 327-329
Session: Nonviral Methods for Delivering Nucleic Acids
Novel Non-Viral Delivery Vehicles That Distribute to the Sciatic Nerve and Brain Identified via Iterative Design-Build-Test-Learn Polymer Nanoparticle Discovery Platform
Ken Sims, Ph.D.
Friday, May 10 - 5:15 PM - 5:30 PM
Location: Room 327-329
Meet Our Speakers
-
Cherry Gupta, Ph.D.
Research ScientistDr. Gupta’s current research is focused on developing translational non-viral drug and gene delivery platforms. As a research scientist at Battelle, she has been leading an internal effort to design, develop and test synthetic nanoparticles. Her areas of expertise include gene and drug delivery, single cell electroporation, understanding of nucleic acid behavior at nanoscale confinement, micro and nanofluidic sensors and various advanced microscopy and characterization techniques. -
Ken Sims, Ph.D.
Co-Founder, Advanced Medicines Campaign (AMC) Team, BattelleKen Sims, PhD, is a co-founding member of Battelle’s Advanced Medicines Campaign (AMC) team and has served as the polymer synthesis and characterization lead as well as a steering committee member for this initiative since 2020. In this role, he is responsible for leading the technical and operational efforts to design, synthesize, purify, and characterize novel polymer nanoparticles for use in a variety of biomedical applications.
Advancing Your Medical Device Innovation
Related Solutions
-
solution
Drug Delivery
Novel therapies are changing the face of medicine. Getting them safely to patients requires innovative drug delivery. When you encounter a challenge where the solution seems just out of reach, or you need a partner in innovation, Battelle’s scientists, engineers, human-centered designers, and world-class facilities can deliver your product to market with confidence. -
solution
Neurotechnology
We transform your neurotechnology and bioelectronic medicine innovations into market-ready solutions. Our experts help you solve your problems, manage your risks and accelerate your development timelines - from concept to FDA registration. -
solution
Medical Technologies for License
We combine deep knowledge, world-class expertise, and specialized facilities to develop disruptive products that solve challenging problems.